Hylton N - Search Results

1

Magnetic resonance imaging insights from active surveillance of women with ductal carcinoma in situ.

Greenwood HI, Maldonado Rodas CK, Freimanis RI, Glencer AC, Miller PN, Mukhtar RA, Brabham C, Yau C, Rosenbluth JM, Hirst GL, Campbell MJ, Borowsky A, Hylton N, Esserman LJ, Basu A. Greenwood HI, et al. Among authors: hylton n. NPJ Breast Cancer. 2024 Aug 4;10(1):71. doi: 10.1038/s41523-024-00677-9. NPJ Breast Cancer. 2024. PMID: 39098868 Free PMC article.

2

Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.

Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Esserman L, et al. Among authors: hylton n. J Clin Oncol. 1999 Jan;17(1):110-9. doi: 10.1200/JCO.1999.17.1.110. J Clin Oncol. 1999. PMID: 10458224

3

Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.

Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM. Kinkel K, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2000 Jul;175(1):35-43. doi: 10.2214/ajr.175.1.1750035. AJR Am J Roentgenol. 2000. PMID: 10882243

4

MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.

Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM. Frei KA, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2000 Dec;175(6):1577-84. doi: 10.2214/ajr.175.6.1751577. AJR Am J Roentgenol. 2000. PMID: 11090379

5

Integration of breast imaging into cancer management.

Esserman LJ, Wolverton D, Hylton N. Esserman LJ, et al. Among authors: hylton n. Curr Oncol Rep. 2000 Nov;2(6):572-81. doi: 10.1007/s11912-000-0112-y. Curr Oncol Rep. 2000. PMID: 11122895 Review.

6

Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma.

Esserman L, Hylton N, George T, Weidner N. Esserman L, et al. Among authors: hylton n. Breast J. 1999 Jan;5(1):13-21. doi: 10.1046/j.1524-4741.1999.005001013.x. Breast J. 1999. PMID: 11348250

7

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.

Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. Esserman L, et al. Among authors: hylton n. Ann Surg Oncol. 2001 Jul;8(6):549-59. doi: 10.1007/s10434-001-0549-8. Ann Surg Oncol. 2001. PMID: 11456056

8

Magnetic resonance imaging for primary breast cancer management: current role and new applications.

Esserman L, Wolverton D, Hylton N. Esserman L, et al. Among authors: hylton n. Endocr Relat Cancer. 2002 Jun;9(2):141-53. doi: 10.1677/erc.0.0090141. Endocr Relat Cancer. 2002. PMID: 12121836 Review.

9

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Partridge SC, Gibbs JE, Lu Y, Esserman LJ, Sudilovsky D, Hylton NM. Partridge SC, et al. AJR Am J Roentgenol. 2002 Nov;179(5):1193-9. doi: 10.2214/ajr.179.5.1791193. AJR Am J Roentgenol. 2002. PMID: 12388497

10

Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity.

Hwang ES, Kinkel K, Esserman LJ, Lu Y, Weidner N, Hylton NM. Hwang ES, et al. Among authors: hylton nm. Ann Surg Oncol. 2003 May;10(4):381-8. doi: 10.1245/aso.2003.03.085. Ann Surg Oncol. 2003. PMID: 12734086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters